NCT01992770

Brief Summary

Background: This study is based on an innovative stepped-care protocol for the management of musculoskeletal pain in primary care, which is evaluated in a RCT. The intervention have two core features: it is theory-driven and include systematic tailoring of treatment content. The tailoring is based on a combination of empirically supported behavioural and medical determinants of pain-related disability and patients' individual perceptions on personal goals, facilitators and barriers for health behavior change. In this application, the intervention is labelled tailored behavioural medicine intervention (TBM). Objectives: The aim is to compare effects and cost-effectiveness of a stepped care model including advice and tailored behavioral medicine pain treatment (experimental condition) with a stepped care model including advice and physical exercises (comparison condition) for patients with low back and neck pain and/or widespread pain including fibromyalgia in primary care. A further aim is to characterize patients who benefit/do not benefit from the respective steps i.e. treatments varying in dose and content. Methods: A stratified randomized stepped care design is applied. Stratification is based on primary care center and patient risk profile. A consecutive selection is performed at primary care centers in southern, central and northern Sweden. According to power analysis, 364 participants should be recruited to allow for sub-group analyses. After having received a minimal intervention (step 1) comprising 'stay-active advice', participants scoring \>90 on the Örebro Musculoskeletal Pain Questionnaire (ÖMPQ) are randomly allocated to an eight-week treatment in step 2. The experimental condition includes supervised physical exercises integrated with either (a) graded activity, or (b) hierarchical graded exposure depending on risk profile, i.e. absence or presence of pain catastrophizing and fear-avoidance beliefs. The comparison condition includes supervised physical exercises irrespective of risk profile. Primary outcome is pain-related disability complemented with a comprehensive set of secondary outcomes adhering to the IMMPACT recommendations. Assessments will be made by personnel blinded for treatment condition at baseline, after step 1 and 2 respectively, and at 12- and 24-month follow-ups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

September 23, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 25, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

December 19, 2019

Status Verified

December 1, 2019

Enrollment Period

2.2 years

First QC Date

September 23, 2013

Last Update Submit

December 17, 2019

Conditions

Keywords

behavioural medicinepainphysical therapyphysical exerciseprimary care

Outcome Measures

Primary Outcomes (1)

  • Changes in pain-related disability including pain severity

    Pain Disability Index The Chronic Pain Grade The Patient Priority Goal Questionnaire (Patient-specific measure for the study of clinical significance and goal attainment)

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

Secondary Outcomes (6)

  • Health related quality of life

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • General health perceptions

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • Sick-absence and disability pension

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • Pain intensity

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • Participants´rating of global improvement and satisfactions with treatment

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • +1 more secondary outcomes

Other Outcomes (4)

  • Sick-leave

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • Prognostic factors

    baseline, after 2 week, post-treatment, 12 months follow-up, 24 months follow-up

  • Demographic and background factors

    baseline

  • +1 more other outcomes

Study Arms (2)

Tailored behavioural medicine

EXPERIMENTAL

After having received a minimal intervention (step 1) comprising 'stay-active advice', participants scoring \>90 on the Örebro Musculoskeletal Pain Questionnaire (ÖMPQ) are randomly allocated to an eight-week treatment in step 2, depending on risk profile. The experimental condition includes supervised physical exercises integrated with either (a) graded activity, or (b) hierarchical graded exposure depending on risk profile, i.e. absence or presence of pain catastrophizing and fear-avoidance beliefs.

Behavioral: Hierarchical graded exposureBehavioral: Graded activityBehavioral: Physical exercises

Control group

ACTIVE COMPARATOR

Participants will be scheduled for supervised, regular Physical exercises twice a week during eight weeks 8. Participants with a "moderate to high disability" risk profile will receive: Tailored graded activities training.

Behavioral: Physical exercises

Interventions

Individual Behavioural goal identification, depending on risk profile (1a). "Catastrophising and/or fear-avoidance" (2); hierarchical graded exposure, organized with individual coaching in connection to the physical training sessions, based on activities that each participant fear and/or avoid.

Tailored behavioural medicine
Graded activityBEHAVIORAL

Individual Behavioural goal identification, depending on risk profile (1b) "Graded activity";(2) self-monitoring of everyday life activities (3) functional behavioural analyses to describe, predict, and verify factors controlling patient's current and future activity performance (4) training of motor skills, cognitive skills, and strategies to organise everyday life including social support. (5) gradual application of acquired skills in everyday life situations as formulated by Specific, Measureable, Activity-related, Realistic, and Time- specified (SMART) goal setting (6) generalisation of skills to additional activities and challenging situations, and (7) strategies for maintenance and relapse prevention.

Tailored behavioural medicine

Participants will be scheduled for supervised, regular physical training twice a week during eight weeks 8

Control groupTailored behavioural medicine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • musculoskeletal pain from the low back, neck or with widespread locations

You may not qualify if:

  • patients scoring high on the Montgomery Åsberg Depression Rating Scale (MADRS; \> 35 or \> 4 on the suicidal risk item)
  • patients suffering from other psychiatric or severe medical co-morbidity (e.g. cancer)
  • patients presenting a history and physical symptoms indicating serious spinal pathology (red flags) implying further diagnostic examination or acute measures.
  • patients not being able to read, write and discuss their everyday life situation in Swedish or accepting an interpreter are not included
  • patients who have completed multimodal treatments due to the current pain condition during the past two years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uppsala University

Uppsala, Sweden

Location

MeSH Terms

Conditions

Musculoskeletal PainPainMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Pernilla Åsenlöf, Professor

    Uppsala University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2013

First Posted

November 25, 2013

Study Start

September 1, 2013

Primary Completion

December 1, 2015

Study Completion

January 1, 2017

Last Updated

December 19, 2019

Record last verified: 2019-12

Locations